LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article ; Online: Evaluation of the cardiovascular risk induced by cannabis use from a series of 43 autopsy cases.

    Paul, Cotier / Charlotte, Mayer / Isabelle, Etting / de la Grandmaison Geoffroy, Lorin / Jean-Claude, Alvarez

    International journal of legal medicine

    2023  Volume 137, Issue 6, Page(s) 1725–1733

    Abstract: The aim of this monocentric observational autopsy study was to confirm the existence of a link between cannabis use and cardiovascular risk. It was based on the analysis of autopsy findings, cardiovascular pathological findings, and toxicological data in ...

    Abstract The aim of this monocentric observational autopsy study was to confirm the existence of a link between cannabis use and cardiovascular risk. It was based on the analysis of autopsy findings, cardiovascular pathological findings, and toxicological data in 43 autopsy cases of people who died with tetrahydrocannabinol (THC) in their blood over a 2-year period. Hair analysis was performed when available (n = 40) to distinguish between occasional and chronic cannabis use and to take into account other possible exposures, including smoking, drug consumption, and the use of other drugs of abuse (mainly cocaine, heroin, and amphetamine). A statistically significant association (Fisher's exact test, p < 0.001) was found between cannabis use, an undetermined manner of death, and the presence of an arrhythmogenic cardiac condition. An association was also found between cannabis use and the presence of advanced coronary heart disease (p = 0.01), heart disease (including ischemic heart disease, p = 0.003), or cardiomyopathy (p = 0.01). Through its systemic vascular action, cannabis could be a factor in triggering sudden death in subjects with arrhythmogenic cardiac conditions. In view of this finding, the mode of death of subjects who died in the presence of THC in the blood would in most cases be an "accident." These results highlight the potential adverse cardiac effects associated with cannabis use.
    Language English
    Publishing date 2023-08-31
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1055109-8
    ISSN 1437-1596 ; 0937-9827
    ISSN (online) 1437-1596
    ISSN 0937-9827
    DOI 10.1007/s00414-023-03079-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application

    Jean Claude Alvarez / Benjamin Davido / Pierre Moine / Isabelle Etting / Djillali Annane / Islam Amine Larabi / Nicolas Simon

    Pharmaceuticals, Vol 15, Iss 256, p

    2022  Volume 256

    Abstract: We develop a population pharmacokinetic model for hydroxychloroquine (HCQ) and three of its metabolites (desethylhydroxychloroquine, Des HCQ; desethylchloroquine, DesCQ; and didesethylchloroquine, didesCQ) in COVID-19 patients in order to determine ... ...

    Abstract We develop a population pharmacokinetic model for hydroxychloroquine (HCQ) and three of its metabolites (desethylhydroxychloroquine, Des HCQ; desethylchloroquine, DesCQ; and didesethylchloroquine, didesCQ) in COVID-19 patients in order to determine whether a pharmacokinetic (PK)/pharmacodynamic (PD) relationship was present. The population PK of HCQ was described using non-linear mixed effects modelling. The duration of hospitalization, the number of deaths, and poor clinical outcomes (death, transfer to ICU, or hospitalization ≥ 10 d) were evaluated as PD parameters. From 100 hospitalized patients (age = 60.7 ± 16 y), 333 BHCQ and M were available for analysis. The data for BHCQ were best described by a four-compartment model with a first-order input (KA) and a first-order output. For M, the better model of the data used one compartment for each metabolite with a first-order input from HCQ and a first-order output. The fraction of HCQ converted to the metabolites was 75%. A significant relationship was observed between the duration of hospitalization and BHCQ at 48 h (r 2 = 0.12; p = 0.0052) or 72 h (r 2 = 0.16; p = 0.0012). At 48 h or 72 h, 87% or 91% of patients vs. 63% or 62% had a duration < 25 d with a BHCQ higher or below 200 μg/L, respectively. Clinical outcome was significantly related to BHCQ at 48 h (good outcome 369 +/− 181 μg/L vs. poor 285 +/− 144 μg/L; p = 0.0441) but not at 72 h (407 +/− 207 μg/L vs. 311 +/− 174 μg/L; p = 0.0502). The number of deaths was not significantly different according to the trough concentration ( p = 0.972 and 0.836 for 48 h and 72 h, respectively).
    Keywords hydroxychloroquine ; desethylhydroxychloroquine ; desethylchloroquine ; didesethylchloroquine ; PK/PD ; COVID-19 ; Medicine ; R ; Pharmacy and materia medica ; RS1-441
    Subject code 333
    Language English
    Publishing date 2022-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk.

    Hanane Bouchghoul / Jean-Claude Alvarez / Céline Verstuyft / Jean Bouyer / Marie-Victoire Senat

    PLoS ONE, Vol 15, Iss 5, p e

    2020  Volume 0232002

    Abstract: BACKGROUND:In pregnant women with gestational diabetes, glyburide can be an alternative to insulin despite concerns about its transplacental transfer. However, transplacental transfer of glyburide is poorly quantified and the relationship between cord ... ...

    Abstract BACKGROUND:In pregnant women with gestational diabetes, glyburide can be an alternative to insulin despite concerns about its transplacental transfer. However, transplacental transfer of glyburide is poorly quantified and the relationship between cord blood glyburide concentration and hypoglycemia has not been studied. Our objective was to quantify the transplacental transfer of glyburide at delivery and to study the association between the cord blood glyburide concentration and the risk of neonatal hypoglycemia in patients with gestational diabetes treated with glyburide. METHODS AND FINDINGS:INDAO was a multicenter, noninferiority, randomized trial conducted between May 2012 and November 2016 in 914 women with singleton pregnancies and gestational diabetes. An ancillary study was conducted in the 87 patients of the Bicêtre University Hospital Center. The sample consisted of 46 patients with utilizable assays at delivery. The relationships between glyburide concentration and the time since the last intake of glyburide and between fetal glyburide concentration and neonatal hypoglycemia were modeled with linear or logistic regressions using fractional polynomials. There was placental transfer of glyburide at a fetal to maternal ratio of 62% (95% CI [50; 74]). Umbilical cord blood glyburide concentration decreased steeply after the last maternal glyburide intake. After 24 hours, the mean umbilical cord blood concentration was less than 5 ng/mL. Neonatal hypoglycemia risk was increased with an odds ratio of hypoglycemia equal to 3.70 [1.40-9.77] for each 10 ng/mL increase in the cord blood glyburide concentration. However, no newborns were admitted to the NICU because of clinical signs of hypoglycemia or for treatment of hypoglycemia. CONCLUSION:Considering that neonatal glyburide exposure may be limited by stopping treatment a sufficient time before labor, there may still be a place for glyburide in the management of gestational diabetes.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2020-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article: LC–MS/MS quantification of free and Fab-bound colchicine in plasma, urine and organs following colchicine administration and colchicine-specific Fab fragments treatment in Göttingen minipigs

    Fabresse, Nicolas / Adrian Thompson / Jean-Claude Alvarez / Julien Allard / Marine Sardaby / Michael Eddleston / R. Eddie Clutton

    Journal of chromatography. 2017 Aug. 15, v. 1060

    2017  

    Abstract: Clinical evaluation of a colchicine specific antigen-binding fragment (Fab) in order to treat colchicine poisoning required the development of an accurate method allowing quantification of free and Fab-bound colchicine in plasma and urine, and free ... ...

    Abstract Clinical evaluation of a colchicine specific antigen-binding fragment (Fab) in order to treat colchicine poisoning required the development of an accurate method allowing quantification of free and Fab-bound colchicine in plasma and urine, and free colchicine in tissues, to measure colchicine redistribution after Fab administration. Three methods have been developed for this purpose, and validated in plasma, urine and liver: total colchicine was determined after denaturation of Fab by dilution in water and heating; free colchicine was separated from Fab-bound colchicine by filtration with 30KDa micro-filters; tissues were homogenized in a tissue mixer. Deuterated colchicine was used as internal standard. Samples were extracted by liquid–liquid extraction and analyzed with a LC–MS/MS. LOQ were 0.5ng/mL in plasma and urine for free and total colchicine and 5pg/mg in tissues. The methods were linear in the 0.5–100ng/mL range in plasma and urine, and 5–300pg/mg in tissues with determination coefficients>0.99. Precision and accuracy of QC samples presented a CV<9.4%. The methods require only 200μL of sample and allow a high throughput due to short analytical run (2min). These methods were successfully applied to a pig intoxicated with colchicine and treated with colchicine specific Fab fragments.
    Keywords chromatography ; clinical examination ; colchicine ; denaturation ; filtration ; liquid-liquid extraction ; liver ; miniature swine ; poisoning ; swine ; tissues ; urine
    Language English
    Dates of publication 2017-0815
    Size p. 400-406.
    Publishing place Elsevier B.V.
    Document type Article
    ISSN 1570-0232
    DOI 10.1016/j.jchromb.2017.06.034
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article: Population pharmacokinetics of methadone hydrochloride after a single intramuscular administration in adult Japanese sika deer (Cervus nippon nippon)

    Scala, Christopher / Amélie Marsot / Jean-Claude Alvarez / Marie-Josée Limoges / Nicolas Simon / Yann Locatelli

    Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesia and Analgesia Veterinary anaesthesia and analgesia. 2015 Mar., v. 42, no. 2

    2015  

    Abstract: To assess the population pharmacokinetics of methadone in deer.Prospective non-randomized experimental trial.Twelve healthy adult sika deer (nine males and three females).Deer received intramuscular administration of racemic methadone hydrochloride at 0 ... ...

    Abstract To assess the population pharmacokinetics of methadone in deer.Prospective non-randomized experimental trial.Twelve healthy adult sika deer (nine males and three females).Deer received intramuscular administration of racemic methadone hydrochloride at 0.5 mg kg−1 or 1 mg kg−1. Plasma methadone and its metabolite 2-Ethylidene-1,5-Dimethyl-3,3-Diphenyl-Pyrolidine (EDDP) concentrations were determined by validated liquid chromatography coupled to tandem mass spectrometry methods, at times 0, 30 minutes, 1, 2, 3, 4, 5, 6, 8, 12 and 24 hours. Population pharmacokinetics analysis was undertaken using a non-linear mixed effects modelling (NONMEM).A two-compartment linear disposition model best described observed time-concentration profiles of methadone and EDDP. Population parameter estimates of methadone were elimination clearance (17.3 L hour−1), metabolic clearance (34.6 L hour−1), volume of distribution of compartment 1 (216.0 L) and volume of distribution of compartment 2 (384.0 L). Population parameter estimates of EDDP were elimination clearance (121.0 L hour−1), volume of distribution of compartment 3 (1.08 L) and volume of distribution of compartment 4 (499.5 L). The total clearance and total volume of distribution of methadone and EDDP were 51.9 L hour−1, 121.0 L hour −1, 600.0 L and 500.6 L, respectively. The methadone terminal elimination half-life was 8.19 hours. No adverse effects were observed after methadone administration.Following intramuscular injection, methadone was characterized by a large total volume of distribution, high systemic clearance and intermediate terminal half-life in sika deer.
    Keywords adults ; adverse effects ; Cervus nippon ; deer ; females ; half life ; intramuscular injection ; liquid chromatography ; males ; metabolites ; methadone ; models ; pharmacokinetics ; tandem mass spectrometry
    Language English
    Dates of publication 2015-03
    Size p. 165-172.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 2020582-X
    ISSN 1467-2995 ; 1467-2987
    ISSN (online) 1467-2995
    ISSN 1467-2987
    DOI 10.1111/vaa.12186
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.

    Philippine Dacosta-Noble / Adrien Costantini / Coraline Dumenil / Jennifer Dumoulin / Pierre Helly de Tauriers / Violaine Giraud / Sylvie Labrune / Jean-François Emile / Jean-Claude Alvarez / Thierry Chinet / Etienne Giroux Leprieur

    PLoS ONE, Vol 14, Iss 7, p e

    2019  Volume 0219080

    Abstract: INTRODUCTION:Patients with advanced non-small cell lung cancer (NSCLC) are most of the time treated with a first-line cytotoxic chemotherapy. Tobacco use is responsible for 90% of lung cancer. The aim of this study was to evaluate the impact of smoking ... ...

    Abstract INTRODUCTION:Patients with advanced non-small cell lung cancer (NSCLC) are most of the time treated with a first-line cytotoxic chemotherapy. Tobacco use is responsible for 90% of lung cancer. The aim of this study was to evaluate the impact of smoking continuation during first-line chemotherapy on tumor response in advanced-stage NSCLC. MATERIALS AND METHODS:All patients with an advanced-stage NSCLC (IIIb or IV), treated with first-line platinum-based chemotherapy in our Department between June 2013 and July 2017 were included. Smoking status was assessed at inclusion by self-report, then at the tumor assessment consultation after 2 months of treatment, by both self-report and plasmatic cotinine measurement. Chemotherapy response, progression-free survival (PFS), overall survival (OS) and stage 3-4 toxicity were registered. RESULTS:Ninety-seven patients were included: 8 (8%) declared to be non-smokers, 56 (58%) current smokers and 33 (34%) former smokers at diagnosis. At the first tumor evaluation, 24 (25%) self-reported as active smokers and 73 (75%) as non-smokers; overall response rate (ORR) was respectively 38% and 48% (p = 0.373). Fifty-four patients had a plasmatic cotinine evaluation at the first tumor evaluation. Seventeen patients (32%) had a positive cotinine rate (median 108ng/mL, IQR 31-236). Six patients (35%) had positive cotinine rate whereas declaring to be non-smokers at the first tumor evaluation. ORR was 18% in case of positive cotinine rate, and 57% when negative (p = 0.007). Regardless of the method for smoking status evaluation, PFS, OS and grade 3-4 toxicities were similar between smoker and non-smoker patients at the first tumor evaluation. CONCLUSION:Smoking continuation during platinum-based chemotherapy, reflected by positive plasma cotinine rate, was associated with a poor ORR.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610 ; 616
    Language English
    Publishing date 2019-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Evaluation of screening for drugs of abuse and benzodiazepines in forensic blood samples using Evidence InvestigatorTM analyser

    Stanislas Grassin Delyle / Bertille Mathieu / Emuri Abe / Jean-Claude Alvarez

    Annales de Toxicologie Analytique, Vol 20, Iss 1, Pp 17-

    2008  Volume 24

    Abstract: Introduction: Semi-quantitative detection of 4 classes of drugs of abuse (opiates, cocaine, cannabinoids and amphetamines) and benzodiazepines in haemolysed whole blood by Evidence Investigator analyser has been evaluated in this study. 128 forensic ... ...

    Abstract Introduction: Semi-quantitative detection of 4 classes of drugs of abuse (opiates, cocaine, cannabinoids and amphetamines) and benzodiazepines in haemolysed whole blood by Evidence Investigator analyser has been evaluated in this study. 128 forensic blood samples known to be positive for at least one of these classes by chromatography coupled to mass spectrometric detection were analysed. Results and discussion: Specificity was 79.0% for amphetamines, 98.1% for cannabinoids, and 100% for opiates, cocaine, and benzodiazepines. Sensitivity was 33.3% for amphetamines, 78.4% for benzodiazepines, 93.2% for cannabinoids, 93.5% for opiates and 95.2% for cocaine. 3.9% of false negatives were observed all classes taken together, due to low concentrations of analytes or due to a bad recognition of some analytes by antibodies. The 4.0% of false positive results were predominantly observed during amphetamines detection, probably due to presence of biogen amines, as it has previously been reported. An improvement of the technique has been carried out by adding a supplementary wash step during sample preparation. An optimisation of cutoff levels is possible to reduce false negative results during benzodiazepines and cannabinoids detection. Conclusion: This immunoanalytical method enables an efficient detection of opiates, cocaine, cannabinoids and benzodiazepines in forensic blood samples. However a further confirmation and quantification by mass spectrometry techniques remains necessary.
    Keywords Drugs of abuse ; whole blood ; biochip ; immunoanalysis ; Toxicology. Poisons ; RA1190-1270 ; Public aspects of medicine ; RA1-1270 ; Medicine ; R ; DOAJ:Public Health ; DOAJ:Health Sciences
    Language French
    Publishing date 2008-01-01T00:00:00Z
    Publisher EDP Sciences
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Survival time estimation using Injury Severity Score (ISS) in homicide cases

    Cros, Jérôme / Emilie Sbidian / Geoffroy Lorin de la Grandmaison / Jean-Claude Alvarez / Philippe Charlier

    Forensic science international. 2013 Dec. 10, v. 233

    2013  

    Abstract: The aim of our study was to assess the value of ISS to estimate survival time in a retrospective study of all homicidal deaths in the Western suburbs of Paris between 1994 and 2008. Stab wounds were the most common cause of death. Survival time between ... ...

    Abstract The aim of our study was to assess the value of ISS to estimate survival time in a retrospective study of all homicidal deaths in the Western suburbs of Paris between 1994 and 2008. Stab wounds were the most common cause of death. Survival time between assault and death, determined in 107 cases out of 511 homicide cases, ranged from 0min to 25 days (mean 39h). There was an overall significant association between the survival time and the ISS score. ISS and survival time were strongly associated with male victims and a clear trend was seen with women. Regarding the type of wounds, a trend was seen with gunshot wounds and blunt injuries, but not with stab wounds. There was no influence of blood toxicological results and resuscitation attempts. Overall, ISS was a good predictor of a survival under 30min.
    Keywords blood ; death ; forensic sciences ; males ; retrospective studies ; women ; France
    Language English
    Dates of publication 2013-1210
    Size p. 99-103.
    Publishing place Elsevier Ireland Ltd
    Document type Article
    ZDB-ID 424042-x
    ISSN 1872-6283 ; 0379-0738
    ISSN (online) 1872-6283
    ISSN 0379-0738
    DOI 10.1016/j.forsciint.2013.08.026
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article ; Online: An epidemic of dystonic reactions in central Africa

    Nicolas Peyraud / Florentina Rafael / Lucy Anne Parker / Michel Quere / Gabriel Alcoba / Christian Korff / Michael Deats / Pernette Bourdillon Esteve / Jean-Clément Cabrol / Micaela Serafini / Iza Ciglenecki / Monica Rull / Islam Amine Larabi / Frédéric Baud / Francesco Grandesso / Benoit Kebela Ilunga / Jean-Claude Alvarez / Paul N Newton

    The Lancet Global Health, Vol 5, Iss 2, Pp e137-e

    2017  Volume 138

    Keywords Public aspects of medicine ; RA1-1270
    Language English
    Publishing date 2017-02-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top